Management - Viking Therapeutics
Brian Lian, Ph.D. President and Chief Executive Officer. Dr. Lian serves as our President and Chief Executive Officer, and as a director.
President & CEO Brian Lian Sells 45,000 Shares of Viking …
Feb 10, 2024 · Viking Therapeutics Inc (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, has reported a significant...
Viking to charge quickly into phase 3 with obesity med - Fierce …
Jul 25, 2024 · CEO Brian Lian, Ph.D., told investors Wednesday afternoon that the company took results from the phase 2 VENTURE trial to the agency to plan the next steps for VK2735. The FDA provided written...
Brian Lian - VKTX | Viking Therapeutics Inc. - Wall Street Journal
Founder of Viking Therapeutics, Inc., Brian Lian is President, Chief Executive Officer & Director at this company. Dr. Lian is also on the board of Seelos Therapeutics, Inc. He previously...
Viking therapeutics CEO sells $8.3 million in stock - Investing.com
5 days ago · SAN DIEGO—Viking Therapeutics, Inc. (NASDAQ: VKTX), a $4.7 billion biotech company, saw its President and CEO Brian Lian recently sell shares worth approximately $8.3 million, according to a ...
President & CEO Brian Lian Sells 269,079 Shares of Viking …
Feb 9, 2024 · Viking Therapeutics Inc (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, has reported a significant...
Viking Therapeutics Announces Initiation of Phase 2 VENTURE …
3 days ago · "The VENTURE-Oral Phase 2 study represents an important milestone for the VK2735 program as we advance two formulations of this compound into later-stage development," said Brian Lian, chief executive officer of Viking Therapeutics. "Prior 28-day Phase 1 data demonstrated encouraging tolerability with the tablet formulation, as well as ...
Brian Lian: Positions, Relations and Network - MarketScreener
Nov 29, 2024 · Brian Lian founded Viking Therapeutics, Inc. in 2012, where he is working as President, Chief Executive Officer & Director. Dr. Lian also currently works at Seelos Therapeutics, Inc., as Independent Director from 2019.
Viking Therapeutics begins VK2735 Phase II trial for obesity …
1 day ago · Viking Therapeutics CEO Brian Lian said: "The VENTURE-Oral Phase 2 study represents an important milestone for the VK2735 program, as we advance two formulations of this compound into later-stage ...
Brian Lian, Ph.D., CEO of Viking Therapeutics - ceobase.io
Apr 5, 2024 · Brian Lian, Ph.D., is the CEO of Viking Therapeutics, Inc., a position he has held since June 2, 2014. His leadership has been key as the company focuses on developing therapies for metabolic and endocrine disorders.
- Some results have been removed